Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Combination of Metformin and Genistein Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Fed Mice Publisher Pubmed



Zamanigarmsiri F1 ; Hashemnia SMR1 ; Shabani M1 ; Bagherieh M1 ; Emamgholipour S1 ; Meshkani R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, I.R, Iran

Source: Journal of Nutritional Biochemistry Published:2021


Abstract

Metformin (MET) and genistein (GEN) have a beneficial role in alleviating non-alcoholic fatty liver disease (NAFLD), but their combined effect on this disease has not yet been studied. The present study aimed to investigate the potential protective effects of combined MET and GEN on NAFLD in high-fat diet (HFD) fed mice. C57BL/6 male mice were fed on an HFD for 10 weeks. Animals were then divided into different groups and treated with MET (0.23%), GEN (0.2%) and MET+GEN (0.23% + 0.2%) for 3 months. Treatment with MET and GEN, alone or in combination significantly lowered body and liver weights and fasting blood glucose (FBG) in HFD mice. Combination therapy reduced liver triglyceride (TG) level and this effect was correlated with increased expression of carnitine palmitoyl transferase 1 (CPT1) gene, and reduced expression of fatty-acid synthase (FAS)and sterol regulatory element-binding protein-1c (SREBP-1c) genes. Combination therapy also affects gluconeogenesis pathway through decreasing expression of Glucose 6-phosphatase (G6Pase) and increasing phosphorylation of Glycogen synthase kinase 3β (GSK-3β). Furthermore, combination of MET and GEN ameliorates liver inflammation by switching macrophage into M2 phenotype, decreasing macrophage infiltration, reducing expression of pro-inflammatory cytokines and decreasing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity. In addition, combination therapy enhances phosphorylation of 5′ adenosine monophosphate-activated protein kinase (AMPK). Taken together, these findings suggest that the combination of MET and GEN have beneficial effects against NAFLD in HFD-fed model. © 2020
Related Docs
View other Related Docs
1. Combination of Metformin and Chlorogenic Acid Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet Fed Mice, IUBMB Life (2021)
2. Metformin in Combination With Genistein Ameliorates Skeletal Muscle Inflammation in High-Fat Diet Fed C57bl/6 Mice, Cytokine (2021)
3. Resveratrol Alleviates Obesity-Induced Skeletal Muscle Inflammation Via Decreasing M1 Macrophage Polarization and Increasing the Regulatory T Cell Population, Scientific Reports (2020)
4. Polyphenols: Potential Anti-Inflammatory Agents for Treatment of Metabolic Disorders, Phytotherapy Research (2022)
5. In-Vitro Synergistic Effect of Metformin and Berberine on High Glucose-Induced Lipogenesis, Iranian Journal of Pharmaceutical Research (2019)
6. Metformin-Chlorogenic Acid Combination Reduces Skeletal Muscle Inflammation in C57bl/6 Mice on High-Fat Diets, Molecular Biology Reports (2023)
7. The Effect of Soy Isoflavones on Non-Alcoholic Fatty Liver Disease and the Level of Fibroblast Growth Factor-21 and Fetuin A, Scientific Reports (2024)
8. Combination Therapy of Metformin and Morin Attenuates Insulin Resistance, Inflammation, and Oxidative Stress in Skeletal Muscle of High-Fat Diet-Fed Mice, Phytotherapy Research (2024)
Experts (# of related papers)
View all Related Experts
Reza Meshkani (16)
Shadi Sadat Seyyedebrahimi (5)
Other Related Docs
9. The French Maritime Pine Bark Extract Reduce Metabolic Syndrome Risk and Improve Body Composition in Obesity: A New Clinical Approach, Acta Medica Iranica (2018)
10. Inhibiting Mir-27A and Mir-142-5P Attenuate Nonalcoholic Fatty Liver Disease by Regulating Nrf2 Signaling Pathway, IUBMB Life (2020)
11. Assessment of Lean Patients With Non-Alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association With Metabolic Disorders: A Cross-Sectional Study, Archives of Iranian Medicine (2017)
12. Metformin Therapy Attenuates Pro-Inflammatory Microglia by Inhibiting Nf-Κb in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis, Neurotoxicity Research (2021)
13. A Review of the Available Remedial Procedures for the Treatment of Fatty Liver Disease, Pakistan Journal of Medical and Health Sciences (2020)
14. The Effect of Soy Isoflavones Supplementation on Metabolic Status in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Placebo Controlled Clinical Trial, BMC Public Health (2024)
15. Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and Jnk/Nf-Κb Pathway in a Sirt1-Independent Mechanism, Journal of Cellular Biochemistry (2017)
16. Healthy Eating Index and Cardiovascular Risk Factors Among Iranian Elderly Individuals, ARYA Atherosclerosis (2017)
17. Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Clinical Therapeutics (2018)
18. Hesperidin Improves Hepatic Steatosis, Hepatic Enzymes, and Metabolic and Inflammatory Parameters in Patients With Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial, Phytotherapy Research (2019)
19. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease, Advances in Nutrition (2021)
20. The Effect of Resveratrol Supplementation on C-Reactive Protein (Crp) in Type 2 Diabetic Patients: Results From a Systematic Review and Meta-Analysis of Randomized Controlled Trials, Complementary Therapies in Medicine (2020)
21. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders, International Journal of Molecular Sciences (2019)
22. Combination Therapy of Metformin and P-Coumaric Acid Mitigates Metabolic Dysfunction Associated With Obesity and Nonalcoholic Fatty Liver Disease in High-Fat Diet Obese C57bl/6 Mice, Journal of Nutritional Biochemistry (2023)
23. Adherence to a Paleolithic Diet in Combination With Lifestyle Factors Reduces the Risk for the Presence of Non-Alcoholic Fatty Liver Disease: A Case-Control Study, Frontiers in Nutrition (2022)
24. The Relation Between Dietary Phytochemical Index and Metabolic Health Status in Overweight and Obese Adolescents, Scientific Reports (2023)
25. Curcumin Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Regulating Jnk/Nf-Kb Pathway and Ros Production, Inflammopharmacology (2018)
26. A Randomized Triple-Blind Controlled Clinical Trial Evaluation of Sitagliptin in the Treatment of Patients With Non-Alcoholic Fatty Liver Diseases Without Diabetes, Frontiers in Medicine (2022)
27. Resveratrol As a Potential Protective Compound Against Skeletal Muscle Insulin Resistance, Heliyon (2023)
28. Resveratrol Supplementation Decreases Blood Glucose Without Changing the Circulating Cd14 + Cd16 + Monocytes and Inflammatory Cytokines in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study, Nutrition Research (2018)
29. Palmitate-Induced Impairment of Autophagy Turnover Leads to Increased Apoptosis and Inflammation in Peripheral Blood Mononuclear Cells, Immunobiology (2018)
30. Lower Serum Levels of Meteorin-Like/Subfatin in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus Are Negatively Associated With Insulin Resistance and Inflammatory Cytokines, PLoS ONE (2018)